Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Receivables (2023 - 2024)

Fractyl Health (GUTS) has disclosed Change in Receivables for 2 consecutive years, with -$7000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Change in Receivables fell 240.0% year-over-year to -$7000.0, compared with a TTM value of -$41000.0 through Dec 2024, down 286.36%, and an annual FY2024 reading of -$22000.0, down 200.0% over the prior year.
  • Change in Receivables was -$7000.0 for Q1 2024 at Fractyl Health, down from -$2000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $51000.0 in Q2 2023 and bottomed at -$32000.0 in Q3 2023.